Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetesInsulin degludec as an ultralong-acting basal insulin once a day: a systematic reviewTreatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approachTeneligliptin in management of type 2 diabetes mellitusAdvances in the treatment of type 2 diabetes: impact of dulaglutideLong-term weight loss maintenance for obesity: a multidisciplinary approachChildhood obesity: prevention is better than cureSodium-glucose cotransporter-2 inhibitor combination therapy to optimize glycemic control and tolerability in patients with type 2 diabetes: focus on dapagliflozin-metforminPrescription omega-3 fatty acid products: considerations for patients with diabetes mellitusPatient considerations in type 2 diabetes - role of combination dapagliflozin-metformin XRRole of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implantEmerging utility of once-weekly exenatide in patients with type 2 diabetesCurrent perspectives on the health risks associated with the consumption of advanced glycation end products: recommendations for dietary managementThe clinical utility of aflibercept for diabetic macular edemaLong-term safety and efficacy of insulin degludec in the management of type 2 diabetesA novel, long-acting glucagon-like peptide receptor-agonist: dulaglutideType 2 diabetes mellitus development programs in the new regulatory environment with cardiovascular safety requirementsIndependent and combined effect of diet and exercise in adults with prediabetesLinking obesity with type 2 diabetes: the role of T-betInhibition of the methionine aminopeptidase 2 enzyme for the treatment of obesityTreating the elderly diabetic patient: special considerationsEffects of combination therapy with mitiglinide and voglibose on postprandial plasma glucose in patients with type 2 diabetes mellitusIs adherence a relevant issue in the self-management education of diabetes? A mixed narrative reviewPsychosocial interventions for the diabetic patientAssessing the obese diabetic patient for bariatric surgery: which candidate do I choose?Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challengesEpigenetic and developmental influences on the risk of obesity, diabetes, and metabolic syndromeOptimal management of type 2 diabetes in patients with increased risk of hypoglycemiaeHealth technologies to support nutrition and physical activity behaviors in diabetes self-managementManagement of pancreatogenic diabetes: challenges and solutionsSources and implications of NADH/NAD(+) redox imbalance in diabetes and its complicationsPractical combination therapy based on pathophysiology of type 2 diabetesRole of sleep quality in the metabolic syndromerDNA insulin glargine U300 - a critical appraisalInterventions to improve long-term weight loss in patients following bariatric surgery: challenges and solutionsStreptozotocin-induced type 1 diabetes in rodents as a model for studying mitochondrial mechanisms of diabetic β cell glucotoxicityEarly-life chemical exposures and risk of metabolic syndromeSingle-donor islet transplantation in type 1 diabetes: patient selection and special considerations.Clinical utility of metabolic syndrome severity scores: considerations for practitioners.Hearing thresholds in adult Nigerians with diabetes mellitus: a case-control study
P1433
Q24628948-FB0B5777-A6BD-4108-AA59-58D1D38065EDQ24630395-279E4A1D-AB7C-416A-A74A-A5DDA8DA60FDQ24635648-16534747-B042-4F8C-A9EF-382B03EF2D6EQ26738356-29A6AF99-17F3-4ED2-AF03-AF6A62D82130Q26746220-282F0FB8-C90F-4865-BB58-59287A245B56Q26751241-E4BA356E-88F5-4182-82E6-21A0796C9F37Q26752810-F8178C67-D867-4E66-948B-F62061ED3C52Q26752815-9F9C9A70-59FD-4ADB-8915-252009EDE097Q26752919-AE1F5228-1835-4D4A-A75A-171C08F2FEC0Q26766404-C7C8662C-3DA0-41DB-B51E-BFE76962DFCEQ26775853-6552B088-92D1-4EDB-9208-7D5DBD017E3AQ26777320-A5D587F4-E72C-49B2-B650-BF689B938F49Q26781156-435FC371-EE0F-4459-A132-A4E201477B72Q26783575-9D2A3134-2444-43A5-B55E-772A56778D07Q26784381-E1EEB757-B417-45F4-9646-369BD1835D77Q26796417-BCACEE8C-0F64-4D33-9A7A-E25DE54391A8Q26801121-3DFCA07F-A9C9-4B6C-826A-295D7F3E0746Q26828591-A1481797-DB22-4902-A945-0228752C80E9Q26830915-6A0FED69-8A73-4445-85A3-8DD6E4E47D0CQ26859210-64B1CE6E-BE7C-406B-8CDF-A03D70717A7DQ26995176-4163C884-60A5-4467-942B-91F8A6805AA6Q26995493-043A0570-243D-48AE-8A6E-037234EF9239Q27008203-B81B7B72-65EF-44AD-9561-00B6F67DE30AQ27008266-E80D5A0E-0E81-4753-B272-5A4B9A6DC356Q27008820-92A8B9B3-5885-4AE4-BB53-6806800645B2Q27010290-896FD550-D867-4A57-849F-2D9F943A0433Q27024609-8D8B5369-B0A4-4AB7-B6AC-B155F5FD7FEDQ27026847-EE3FBAA1-A356-4D6E-8C52-0AB3E2E32F44Q28067178-70948BB2-EAF3-4E60-B390-AAFBC83DC604Q28069386-987DC35D-BB89-4E91-B137-B349617A2592Q28076120-7B170D03-5817-44DD-943D-5667D4B5B95EQ28076530-AC323803-440F-48DF-8D5E-D4F1E3090D72Q28076751-8835CDF7-FFCA-465D-BD4B-D90BD359ED98Q28077366-40D77015-B760-4D17-9812-8EED0CD9DF0FQ28085070-0C3AF081-2837-48FD-A9DA-BD92CFA1A5E9Q28260875-4CA24027-2A6F-43BA-9E68-6AEF482E88C9Q29248098-77F6450B-ECD8-4A34-9BE3-FA7231499A0EQ30252993-231DFA50-E1ED-4865-B34F-CD060474E227Q30253051-5EC9758B-BD14-4B09-B4A6-AD932D8EDD01Q30356853-CEED7506-11C5-4C2D-A7A6-65C45DFB194D
P1433
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
description
journal
@en
revista científica
@es
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift van Dove Medical Press
@nl
wissenschaftliche Fachzeitschrift
@de
مجلة
@ar
वैज्ञानिक पत्रिका
@hi
name
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
@ast
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
@en
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
@es
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
@it
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
@nl
type
label
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
@ast
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
@en
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
@es
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
@it
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
@nl
altLabel
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
@en
prefLabel
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
@ast
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
@en
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
@es
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
@it
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
@nl
P31
P243
P3181
P4616
P1055
P1058
P1156
19700174905
P1476
Diabetes, Metabolic Syndrome and Obesity
@en
P1680
Targets and Therapy
@en
P236
P243
P3181
P407
P5115
P571
2008-01-01T00:00:00Z